KaloCyte Welcomes Lyophilization Expert to its Baltimore Headquarters

Published on :

KaloCyte Welcomes Lyophilization Expert to its Baltimore Headquarters Nivesh Mittal, Ph.D., Product Development Scientist, to propel production of ErythroMer™   March 24, 2020, Baltimore, Md. – KaloCyte, Inc., a preclinical-stage healthcare biotechnology company developing ErythroMer, a synthetic, bio-inspired red blood cell substitute for use in settings when stored red blood cells are not available, today announced the hiring [….]

Adam Van Bavel Joins Workforce Genetics & BioBuzz to Lead Marketing & Business Development

Published on :

Adam Van Bavel Joins Workforce Genetics & BioBuzz to Lead Marketing & Business Development Workforce Genetics welcomes Adam Van Bavel as the new Head of Marketing and Business Development. Adam will be the head storyteller conveying the vision for both the Talent and BioBuzz divisions which offer services across several functional areas, including; publishing, events, [….]

VerImmune Inc Appoints Oncology Veteran as Interim Chief Business Officer

Published on :

VerImmune Inc Appoints Oncology Veteran as Interim Chief Business Officer A biotech industry veteran in oncology to lead business development and alliance-building efforts for VerImmune’s proprietary Anti-tumor Immune Redirection (AIR) platform Baltimore, Maryland – Feb 14th, 2020 – VerImmune, Inc., a privately-owned immuno-oncology biotechnology company developing a first-in-class broad-spectrum cancer therapy for solid tumors based on [….]

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer

Published on :

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer GAITHERSBURG, Md., Jan. 09, 2020 (Excerpts below were originally published on GLOBE NEWSWIRE) NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veteran John Trainer, MBA has been appointed as the [….]

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team

Published on :

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team GAITHERSBURG, Md., Jan. 09, 2020 (originally published on GLOBE NEWSWIRE) NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veterans Han Myint, MD has been appointed as the Company’s Chief Medical Officer. Additionally, [….]

Benjamin H. Wu Selected as President and CEO of the Montgomery County Economic Development Corporation

Published on :

Benjamin H. Wu Selected as President and CEO of the Montgomery County Economic Development Corporation Top Maryland official named as MCEDC executive to lead business growth in Montgomery County, the state’s economic driver ROCKVILLE, Md.—(BUSINESS WIRE)—The Board of Directors of the Montgomery County Economic Development Corporation (MCEDC) has announced Benjamin H. Wu as its new [….]

Emmes Names Lynn Lewis Chief Business Officer

Published on :

Emmes Names Lynn Lewis Chief Business Officer Monday, November 25, 2019 Emmes today announced that Lynn Lewis has joined the company as chief business officer, a newly created position. Her overall focus is to build deeper relationships with existing clients and to develop new business opportunities, particularly among biotech and pharmaceutical companies. Lewis will be [….]

ATCC Appoints Dr. Raymond D. Stapleton President and Chief Operating Officer

Published on :

ATCC Appoints Dr. Raymond D. Stapleton President and Chief Operating Officer Manassas, VA – November 19, 2019 – ATCC, the world’s premier biological materials resource and standards organization, today announced the appointment of Raymond D. Stapleton, Jr., Ph.D., to the role of President and Chief Operating Officer. With extensive management experience in translational sciences and the [….]

Todd Chappell Appointed CEO of Rasio Therapeutics

Published on :

Todd Chappell  Appointed CEO of Rasio Therapeutics Chappell is a 20-year veteran of the biopharma industry with experience running multiple drug development programs from the discovery stage through to clinical trials November 14, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the appointment of Todd Chappell, a veteran medtech and [….]